Description
Ansomone is a human growth hormone that has the same effects as the hormone naturally produced in the body. It can help to increase the rate of linear growth and widen epiphyses, as well as promote protein synthesis throughout the body.
It can also help to reverse the negative nitrogen equilibrium caused by injury or surgery, correct hypoproteinemia due to severe infections or liver cirrhosis, stimulate the synthesis of immunoglobulins and the proliferation of lymphocytes, macrophages and lymphadenoid, and help to speed up wound healing.
Additionally, it can help to improve cardiac contractility and reduce cardiac oxygen consumption, regulate lipometabolism and lower cholesterol and low-density lipoprotein levels. It can also be used to complement insufficiencies or deficiencies of growth hormone, regulate lipometabolism, osteometabolism, heart and kidney functions in adults.
Ansomone can be administered both subcutaneously and intramuscularly. While subcutaneous administration may lead to higher concentrations of GH in the plasma, intramuscular administration also increases IGF-1 hormone levels.
Usage
Ansomone is a medication used to treat growth failure in children and severe burns. The recommended dosage for growth failure is 0.1-0.15IU/kg of body weight per day, administered subcutaneously over a period of three months to three years.
For severe burns, the recommended dosage is 0.2-0.14IU/kg of body weight per day, administered subcutaneously over a period of two weeks. The therapy regimen may be modified according to the advice of an experienced doctor. When administering the medication, 1 ml of sterile water for injection should be injected along the bottle wall, then the vial should be gently swirled until the contents are completely dissolved. Shaking the vial violently should be avoided.
Reviews
There are no reviews yet.